Hugh S Taylor Selected Research

Breast Neoplasms (Breast Cancer)

1/2018	Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update.
10/2016	Endometrial Cancer-Associated FGF18 Expression Is Reduced by Bazedoxifene in Human Endometrial Stromal Cells In Vitro and in Murine Endometrium.
1/2016	Bisphenol A (BPA) Exposure In Utero Leads to Immunoregulatory Cytokine Dysregulation in the Mouse Mammary Gland: A Potential Mechanism Programming Breast Cancer Risk.
9/2015	The Effect of Menopausal Hormone Therapies on Breast Cancer: Avoiding the Risk.
7/2015	Effects of ospemifene on the female reproductive and urinary tracts: translation from preclinical models into clinical evidence.
2/2011	Update in hormone therapy use in menopause.
6/2010	In utero exposure to diethylstilbestrol (DES) or bisphenol-A (BPA) increases EZH2 expression in the mammary gland: an epigenetic mechanism linking endocrine disruptors to breast cancer.
6/2004	HOXA10 regulates p53 expression and matrigel invasion in human breast cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hugh S Taylor Research Topics

Disease

92	Endometriosis 06/2023 - 05/2004
18	Pain (Aches) 12/2021 - 01/2017
17	Neoplasms (Cancer) 01/2022 - 06/2004
16	Infertility (Sterility) 01/2024 - 05/2011
12	Leiomyoma (Uterine Fibroids) 03/2024 - 11/2002
11	Inflammation (Inflammations) 01/2022 - 02/2009
11	Pelvic Pain 01/2021 - 01/2017
10	Atherosclerosis 01/2022 - 06/2010
8	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2023 - 01/2003
8	Dysmenorrhea (Menstrual Pain) 01/2021 - 01/2017
8	Breast Neoplasms (Breast Cancer) 01/2018 - 06/2004
7	Insulin Resistance 01/2022 - 08/2007
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 08/2003
5	Hemorrhage 12/2022 - 07/2009
5	Dyspareunia 01/2021 - 07/2015
5	Adenocarcinoma 10/2016 - 03/2002
4	Obesity 10/2022 - 01/2017
4	Hyperglycemia 01/2022 - 11/2011
4	Gynatresia 01/2018 - 01/2014
4	Endometrial Hyperplasia 10/2016 - 04/2012
3	Menorrhagia 03/2024 - 02/2011
3	Infections 01/2022 - 06/2006
3	Ectopic Pregnancy 01/2021 - 05/2004
3	Myoma 01/2020 - 04/2010
3	Chronic Disease (Chronic Diseases) 11/2019 - 11/2018
3	Endometrial Neoplasms (Endometrial Cancer) 01/2017 - 07/2015
3	Hyperplasia 10/2016 - 02/2013
3	Body Weight (Weight, Body) 08/2014 - 11/2003
2	Overweight 01/2023 - 08/2013
2	Uterine Hemorrhage (Uterine Bleeding) 12/2022 - 11/2020
2	Hyperinsulinism (Hyperinsulinemia) 10/2022 - 01/2018
2	Maternal Obesity 10/2022 - 01/2018
2	COVID-19 01/2022 - 01/2021
2	Spontaneous Abortion (Miscarriage) 01/2021 - 06/2008

Drug/Important Bio-Agent (IBA)

39	Estrogens (Estrogen)FDA Link 01/2023 - 08/2003
18	MicroRNAs (MicroRNA)IBA 12/2023 - 12/2011
16	Gonadotropin-Releasing Hormone (GnRH)FDA Link 03/2024 - 09/2003
16	Hormones (Hormone)IBA 01/2024 - 02/2009
14	Messenger RNA (mRNA)IBA 04/2021 - 03/2002
11	elagolixIBA 03/2024 - 01/2017
11	Estradiol (Delestrogen)FDA LinkGeneric 01/2022 - 06/2004
11	Progestins (Progestagens)IBA 01/2020 - 06/2006
10	bazedoxifeneIBA 06/2018 - 05/2009
9	Proteins (Proteins, Gene)FDA Link 04/2021 - 10/2008
9	Progesterone FDA LinkGeneric 11/2020 - 01/2005
8	Progesterone Receptors (Progesterone Receptor)IBA 01/2023 - 01/2009
8	Insulin (Novolin)FDA Link 10/2022 - 08/2007
8	CytokinesIBA 01/2022 - 06/2006
8	Selective Estrogen Receptor Modulators (SERM)IBA 10/2016 - 05/2009
7	SteroidsIBA 01/2022 - 11/2005
7	Biomarkers (Surrogate Marker)IBA 10/2020 - 05/2015
7	Conjugated (USP) Estrogens (Premarin)FDA Link 01/2019 - 04/2014
6	Testosterone (Sustanon)FDA Link 01/2023 - 01/2003
6	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 08/2007
5	AndrogensIBA 01/2023 - 01/2003
5	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2018
5	Analgesics (Analgesic Drugs)IBA 01/2021 - 01/2017
5	Estrogen ReceptorsIBA 01/2020 - 01/2015
4	Endocrine DisruptorsIBA 01/2023 - 06/2010
4	salicylhydroxamic acid (SHAM)IBA 01/2023 - 01/2018
4	ChemokinesIBA 01/2023 - 01/2017
4	bisphenol AIBA 01/2023 - 06/2010
4	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 01/2022 - 01/2020
4	Long Noncoding RNAIBA 01/2019 - 08/2015
4	EnzymesIBA 01/2019 - 01/2017
3	linzagolixIBA 03/2024 - 01/2020
3	Letrozole (Femara)FDA LinkGeneric 01/2023 - 05/2012
3	LigandsIBA 01/2023 - 01/2018
3	C-Reactive ProteinIBA 03/2022 - 03/2012
3	Immunoconjugates (Immunoconjugate)IBA 12/2020 - 02/2010
3	Simvastatin (Zocor)FDA LinkGeneric 10/2019 - 07/2012
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2017 - 09/2011
3	Homeobox A10 ProteinsIBA 02/2016 - 12/2010
3	OspemifeneIBA 07/2015 - 05/2009
3	mahuang-tangIBA 06/2015 - 01/2013
3	Gonadal Steroid Hormones (Sex Hormones)IBA 02/2011 - 09/2009
3	SodiumIBA 09/2009 - 11/2003
2	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2024 - 01/2023
2	TeaIBA 01/2024 - 01/2023
2	Clomiphene (Clomifene)FDA LinkGeneric 01/2023 - 05/2012
2	Triclosan (pHisoHex)FDA Link 01/2023 - 09/2022
2	Integrin alphaVbeta3IBA 01/2023 - 01/2010
2	Insulin-Like PeptidesIBA 10/2022 - 01/2009
2	Triglycerides (Triacylglycerol)IBA 10/2022 - 01/2022
2	HDL LipoproteinsIBA 03/2022 - 01/2022
2	ApolipoproteinsIBA 01/2022 - 08/2014
2	oil red OIBA 01/2022 - 01/2018
2	InterleukinsIBA 01/2022 - 01/2018
2	plerixafor FDA Link 01/2022 - 01/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2018
2	CholesterolIBA 01/2022 - 01/2020
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2021
2	Opioid Analgesics (Opioids)IBA 01/2021 - 01/2019

Therapy/Procedure

37	Therapeutics 03/2024 - 08/2007
6	Hysterectomy 03/2022 - 11/2002
4	Transplantation 01/2021 - 08/2007
3	Ovariectomy (Oophorectomy) 03/2022 - 01/2018
3	Intraperitoneal Injections 01/2019 - 01/2011
2	Aftercare (After-Treatment) 01/2023 - 01/2020
2	Curettage 12/2022 - 01/2021